Zusammensetzung information

Zusammensetzung, Synonyme

• Immunoglobulin G1, anti-(vascular endothelial growth factor receptor 2 (EC 2.7.10.1 or protein-tyrosine kinase receptor Flk-1 or CD309 antigen) extracellular domain); human monoclonal IMC-1121B γ1 heavy chain (219-214 )-disulfide with human monoclonal IMC-1121B κ light chain (225-225 :228-228 )-bisdisulfide dimer
• IMC-1121B (ImClone)
• Ramucirumabum
• Immunoglobulin G1-kappa, anti-[Homo sapiens vascular endothelial growth factor receptor 2 (VEGFR2, KDR, kinase insert domain receptor, FLK1, CD309) extracellular domain], Homo sapiens monoclonal antibody; gamma1 heavy chain (1-446) [Homo sapiens VH (IGHV3-21*01(99.00%)-(IGHD)-IGHJ3*02) [8.8.9] (1-116)-IGHG1*03, R120>K (117-446)], (219-214 )-disulfide with kappa light chain (1 -214 ) [Homo sapiens V-KAPPA (IGKV1-12*01 (85.30%)-IGKJ4*01, E125>D) [6.3.9] (1 -107 )-IGKC*01, R1.4>G (108 -214 )]; (225
• Immunoglobulin G1-kappa, anti-[Homo sapiens KDR (kinase insert domain receptor, vascular endothelial growth factor receptor 2, VEGFR2, VEGF-R2, FLK1, CD309) extracellular domain], Homo sapiens monoclonal antibody; gamma1 heavy chain (1-446) [Homo sapiens VH (IGHV3-21*01(99.00%)-(IGHD)-IGHJ3*02) [8.8.9] (1-116)-IGHG1*03 (CH1 F5>L (125), hinge (215-229), CH2 (230-339), CH3 (340-444), CHS (445-446)) (117-446)], (219-214 )-disulfide with kappa light chain (1 -214 ) [Homo sapiens V-KAPPA (IGKV1-12*01
• Ramucirumab

Andere Arzneimittel